Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Multiple sclerosis].
Confavreux C, Gignoux L. Confavreux C, et al. Among authors: gignoux l. Rev Prat. 2002 Mar 1;52(5):529-38. Rev Prat. 2002. PMID: 11949507 French. No abstract available.
Steroid hormones in multiple sclerosis.
El-Etr M, Vukusic S, Gignoux L, Durand-Dubief F, Achiti I, Baulieu EE, Confavreux C. El-Etr M, et al. Among authors: gignoux l. J Neurol Sci. 2005 Jun 15;233(1-2):49-54. doi: 10.1016/j.jns.2005.03.004. J Neurol Sci. 2005. PMID: 15878598 Review.
History of multiple sclerosis in 2 successive pregnancies: A French and Italian cohort.
Benoit A, Durand-Dubief F, Amato MP, Portaccio E, Casey R, Roggerone S, Androdias G, Gignoux L, Ionescu I, Marrosu MG, Cocco E, Ghezzi A, Annovazzi P, Trojano M, Simone M, Marignier R, Confavreux C, Vukusic S. Benoit A, et al. Among authors: gignoux l. Neurology. 2016 Sep 27;87(13):1360-7. doi: 10.1212/WNL.0000000000003036. Epub 2016 Jul 27. Neurology. 2016. PMID: 27466470
Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study.
Papeix C, Castelnovo G, Leray E, Coustans M, Levy P, Visy JM, Kobelt G, Lamy F, Allaf B, Heintzmann F, Chouette I, Raponi E, Durand B, Grevat E, Kamar D, Debouverie M, Lebrun-Frenay C; Virgile Study Group. Papeix C, et al. Neurol Ther. 2022 Jun;11(2):633-658. doi: 10.1007/s40120-022-00334-y. Epub 2022 Feb 11. Neurol Ther. 2022. PMID: 35147904 Free PMC article.
Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis.
Androdias G, Noroy L, Psimaras D, Birzu C, Pelletier J, Beigneux Y, Branger P, Ciron J, Dananchet Y, Depaz R, Froment Tilikete C, Gignoux L, Grosset-Janin C, Joubert B, Kerschen P, Kwiatkowski A, Lebrun-Frenay C, Maillart E, Maureille A, Nicolas P, Roux T, Marignier R, Vukusic S; as the ICI-SEP group, under the aegis of the Société Francophone de la Sclérose en Plaques (SFSEP). Androdias G, et al. Among authors: gignoux l. Neurol Neuroimmunol Neuroinflamm. 2024 Mar;11(2):e200202. doi: 10.1212/NXI.0000000000200202. Epub 2024 Feb 12. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38346268 Free PMC article.
16 results